We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.6B
AUM Growth
+$879M
(+4.7%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-6.05%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
589
New
74
Increased
137
Reduced
233
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$96.2M |
| 2 |
DraftKings
DKNG
|
+$81.7M |
| 3 |
GE HealthCare
GEHC
|
+$81.1M |
| 4 |
GFL Environmental
GFL
|
+$77M |
| 5 |
Vaxcyte
PCVX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$187M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$143M |
| 3 |
AbbVie
ABBV
|
+$112M |
| 4 |
Walt Disney
DIS
|
+$99.6M |
| 5 |
HSKA
Heska Corp
HSKA
|
+$80.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 10.17% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Biogen
BIIB
$29.5B
| $35.9M | 0.18% |
125,980
-143,458
| -53% | -$42.7M |
|
127
CoStar Group
CSGP
$11.9B
| $35.9M | 0.18% |
403,204
-65,823
| -14% | -$5.08M |
|
128
Booking.com
BKNG
$145B
| $35.4M | 0.18% |
327,275
-183,275
| -36% | -$19.4M |
|
|
INVX
129
Innovex International
INVX
$1.85B
| $33.9M | 0.17% |
1,455,561
-79,271
| -5% | -$2.02M |
|
130
Palo Alto Networks
PANW
$259B
| $33.2M | 0.17% |
260,146
-316,732
| -55% | -$33M |
|
131
Q2 Holdings
QTWO
$3.64B
| $33M | 0.17% |
1,069,556
-220,875
| -17% | -$5.79M |
|
132
Nike
NKE
$62.5B
| $32.8M | 0.17% |
297,258
-412,622
| -58% | -$48.3M |
|
133
Uber
UBER
$139B
| $31.8M | 0.16% |
736,021
-1,370,279
| -65% | -$50.9M |
|
134
Ascendis Pharma A/S
ASND
$16.6B
| $31.3M | 0.16% |
+351,011
| New | +$30.5M |
|
135
US Physical Therapy
USPH
$1.17B
| $30.8M | 0.16% |
253,328
+2,777
| +1% | +$299K |
|
136
Ultragenyx Pharmaceutical
RARE
$2.65B
| $30.3M | 0.15% |
656,105
+112,553
| +21% | +$5.22M |
|
|
MODN
137
DELISTED
MODEL N, INC.
MODN
| $30.1M | 0.15% |
852,422
+186,398
| +28% | +$5.99M |
|
|
AXNX
138
DELISTED
Axonics, Inc. Common Stock
AXNX
| $30M | 0.15% |
594,870
-236,870
| -28% | -$12.6M |
|
139
Definitive Healthcare
DH
$71.1M
| $29.5M | 0.15% |
2,684,794
+158,474
| +6% | +$1.63M |
|
140
Alphatec Holdings
ATEC
$1.33B
| $28.2M | 0.14% |
+1,569,438
| New | +$24.4M |
|
141
RXO
RXO
$3.98B
| $27.7M | 0.14% |
1,222,215
+110,304
| +10% | +$2.22M |
|
|
NVRO
142
DELISTED
NEVRO CORP.
NVRO
| $27.6M | 0.14% |
1,086,937
-87,306
| -7% | -$2.52M |
|
143
HubSpot
HUBS
$11.4B
| $27.3M | 0.14% |
51,332
-3,928
| -7% | -$1.84M |
|
144
Vicor
VICR
$9.41B
| $26.9M | 0.14% |
+497,789
| New | +$24.6M |
|
|
NARI
145
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $26.3M | 0.13% |
+452,738
| New | +$28.6M |
|
|
146
AbbVie
ABBV
$454B
| $24.7M | 0.13% |
182,976
-765,484
| -81% | -$112M |
|
|
HES
147
DELISTED
Hess
HES
| $24.5M | 0.13% |
+180,155
| New | +$24.7M |
|
|
SUM
148
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $24.1M | 0.12% |
+635,637
| New | +$19.7M |
|
149
Rambus
RMBS
$10.4B
| $22.7M | 0.12% |
+353,441
| New | +$19.5M |
|
150
Paycom
PAYC
$7.05B
| $22M | 0.11% |
68,514
-15,073
| -18% | -$4.44M |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2023 Portfolio in Review
As of Q2 2023, Fred Alger Management held 589 positions worth $19.6B, up 4.7% from $18.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fred Alger Management withdrew a net $1.18B in Q2 2023, closing 78 positions and reducing 233 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in DraftKings worth $94.2M.
- Fred Alger Management's largest Q2 2023 buy was DraftKings: 3,544,411 shares worth $94.2M.
- Fred Alger Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $96.2M increase.
- Fred Alger Management's biggest Q2 2023 reduction was Intuit, cutting an estimated $187M.
- Fred Alger Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $143M.
- Fred Alger Management's ten largest holdings make up 34% of its $19.6B portfolio in Q2 2023.
- Fred Alger Management opened 74 new positions and closed 78 in Q2 2023.
- Fred Alger Management's portfolio value rose 4.7% quarter-over-quarter to $19.6B.
Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.